I would also note I believe that the mice utilized in the tests were of an inbread nature and potenially geared more toward genetic study with stem cell products or the like versus mice like Dr. Harris's geared toward the study of infectious desease like Dengue and antibody dependent enhancement aspect.
While her model is likely much more applicable to efficacy, I wonder if it would matter to much from a nanotoxin investigative standpoint which to use. I would think maybe some other mouse design is best to evaluate toxicities.
New money. How will you feel when/if NNVC sails through its clinical trials for flu ied and the sp is north of $100. Short term gain for a long term pain? Remember Saul of Tarsus's conversion. There is still time for you to do a u-turn avoid a lifetime of regret and gain an independent lifestyle - mate!
News 
Market Data 
Discover 
